AtriCure | Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 42M 2M 2025-12
Artivion USD 7.83M 1.22M 2024-03
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Cooper Companies USD 24.4M 1000K 2025-09
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Globus Medical USD 5.1B 5.1B 2025-09
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 22.72M 1.68M 2025-09
Intuitive Surgical USD 19.35B 811.4M 2025-09
J&J USD 18M 290M 2025-09
Masimo USD 8.8M 600K 2025-09
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.78M 207K 2025-06
ResMed USD 8.79M 14.55M 2025-09
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 31.84M 10.13M 2025-09
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12


AtriCure Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.